MSB Stock Discussion

Mesoblast limited   Description

Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Diseases Life Sciences Biology Disorders Stem Cell Stem Cells Cell Biology Induced Stem Cells